In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

During the COVID-19 pandemic, healthcare workers faced several mental health challenges, experiencing repeated exposure to ...

An intervention program that coaches patients in stress management and goal setting, along with a digital app, helped ...

Gene therapies have a lot of potential to improve health outcomes for patients with life-threatening diseases but face a ...

Lindsay Bealor Greenleaf, JD, MBA; Ryann Hill, MPH; Patrick Cooney ...

The campaign for hand eczema is the latest in a number of high-cost campaigns to raise awareness of dermatological conditions ...

Short-term hormone therapy lasting four years initiated within three years of the last menstrual cycle had no long-term ...

In a recent conversation with Greg Baker, CEO of AffirmedRx, the PBM professional outlined the company’s distinct approach in the PBM industry with MHE editors.

After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked ...

President-elect Donald Trump announced last Thursday, Nov. 14, that Kennedy, 70, was his pick to head the Department of ...

The FDA has approved UCB's Bimzelx for moderate-to-severe hidradenitis suppurativa, offering a new treatment option for this ...

Monjuvi is available under an accelerated approval to treat adults with relapsed or refractory diffuse large B-cell lymphoma.